SREBF1 and metabolic dysfunction-associated steatotic liver disease: In light of our observation of a strong association of circulating BCKA and hepatic BCKDK expression with NAFLD/NASH in people with severe obesity we aimed to determine whether another major lipogenic transcription factor, SREBP1 might also regulate hepatic BCKDK gene expression.